Half of all drug trials in Europe fail to report results as required by law, a new study has found. Of 234 drug trials that had become due to report results, only 116 had reported results on time. A further 20 trials reported results late, and 98 trials completely failed to make substantive results public. New law widely ignored Under a law that came into force in 2022, pharma companies and universities running clinical trials of medicines in Europe are obliged to make their results...

America’s medicines regulator has chased up thousands of missing clinical trial results with universities and pharma and medical device companies. This is big news. For most of these institutions, it will be the first time they have ever heard from the FDA about their legal obligations. In a press release, the FDA announced that: “Far too often, companies are suppressing unfavorable clinical trial results and keeping them secret from patients and the scientific community.” “On March 30,...

The European Medicines Agency has just released its quarterly data update on drug trials conducted within Europe. The charts below provide an overview of new initial clinical trial applications from January 2022 until the end of 2025. While not all of those studies will have been approved, the data provide a nice heuristic overview of drug trial volume and composition by country. Number of drug trials per country Patients in Spain, France, Germany, Italy and – maybe surprisingly – Poland...